Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-06-04

AUTHORS

David F. McDermott, Mahrukh A. Huseni, Michael B. Atkins, Robert J. Motzer, Brian I. Rini, Bernard Escudier, Lawrence Fong, Richard W. Joseph, Sumanta K. Pal, James A. Reeves, Mario Sznol, John Hainsworth, W. Kimryn Rathmell, Walter M. Stadler, Thomas Hutson, Martin E. Gore, Alain Ravaud, Sergio Bracarda, Cristina Suárez, Riccardo Danielli, Viktor Gruenwald, Toni K. Choueiri, Dorothee Nickles, Suchit Jhunjhunwala, Elisabeth Piault-Louis, Alpa Thobhani, Jiaheng Qiu, Daniel S. Chen, Priti S. Hegde, Christina Schiff, Gregg D. Fine, Thomas Powles

ABSTRACT

We describe results from IMmotion150, a randomized phase 2 study of atezolizumab (anti-PD-L1) alone or combined with bevacizumab (anti-VEGF) versus sunitinib in 305 patients with treatment-naive metastatic renal cell carcinoma. Co-primary endpoints were progression-free survival (PFS) in intent-to-treat and PD-L1+ populations. Intent-to-treat PFS hazard ratios for atezolizumab + bevacizumab or atezolizumab monotherapy versus sunitinib were 1.0 (95% confidence interval (CI), 0.69–1.45) and 1.19 (95% CI, 0.82–1.71), respectively; PD-L1+ PFS hazard ratios were 0.64 (95% CI, 0.38–1.08) and 1.03 (95% CI, 0.63–1.67), respectively. Exploratory biomarker analyses indicated that tumor mutation and neoantigen burden were not associated with PFS. Angiogenesis, T-effector/IFN-γ response, and myeloid inflammatory gene expression signatures were strongly and differentially associated with PFS within and across the treatments. These molecular profiles suggest that prediction of outcomes with anti-VEGF and immunotherapy may be possible and offer mechanistic insights into how blocking VEGF may overcome resistance to immune checkpoint blockade. More... »

PAGES

749-757

Journal

TITLE

Nature Medicine

ISSUE

6

VOLUME

24

Author Affiliations

  • Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Genentech, Inc., South San Francisco, CA, USA
  • Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
  • Gustave Roussy, Villejuif, France
  • University of California, San Francisco School of Medicine, San Francisco, CA, USA
  • Mayo Clinic Hospital – Florida, Jacksonville, FL, USA
  • City of Hope Comprehensive Cancer Center, Duarte, CA, USA
  • Florida Cancer Specialists, Fort Myers, FL, USA
  • Yale School of Medicine, New Haven, CT, USA
  • Sarah Cannon Research Institute, Nashville, TN, USA
  • Vanderbilt University Medical Center, Nashville, TN, USA
  • University of Chicago Medicine, Chicago, IL, USA
  • Texas Oncology – Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA
  • Royal Marsden Hospital, London, UK
  • CHU Hopitaux de Bordeaux – Hôpital Saint-André, Bordeaux, France
  • Ospedale San Donato, Azienda USL Toscana Sudest, Arezzo, Italy
  • Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
  • Azienda Ospedaliera Universitaria Senese, Center for Immune-Oncology, Siena, Italy
  • Medizinische Hochschule, Zentrum Innere Medizin, Abt. Hämatologie u. Onkologie, Hannover, Germany
  • Dana-Farber Cancer Institute, Boston, MA, USA
  • Roche Products Ltd, Welwyn Garden City, UK
  • Barts Cancer Institute and the Royal Free Hospital, Queen Mary University of London, London, UK
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41591-018-0053-3

    DOI

    http://dx.doi.org/10.1038/s41591-018-0053-3

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1104306675

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/29867230


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal, Humanized", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Combined Chemotherapy Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bevacizumab", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma, Renal Cell", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Profiling", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Regulation, Neoplastic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kaplan-Meier Estimate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kidney Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mutation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sunitinib", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Beth Israel Deaconess Medical Center, Boston, MA, USA", 
              "id": "http://www.grid.ac/institutes/grid.239395.7", 
              "name": [
                "Beth Israel Deaconess Medical Center, Boston, MA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McDermott", 
            "givenName": "David F.", 
            "id": "sg:person.0656541200.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656541200.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Huseni", 
            "givenName": "Mahrukh A.", 
            "id": "sg:person.013034331475.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013034331475.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA", 
              "id": "http://www.grid.ac/institutes/grid.213910.8", 
              "name": [
                "Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Atkins", 
            "givenName": "Michael B.", 
            "id": "sg:person.010266621557.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010266621557.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Memorial Sloan Kettering Cancer Center, New York, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.51462.34", 
              "name": [
                "Memorial Sloan Kettering Cancer Center, New York, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Motzer", 
            "givenName": "Robert J.", 
            "id": "sg:person.01234500340.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234500340.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA", 
              "id": "http://www.grid.ac/institutes/grid.239578.2", 
              "name": [
                "Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rini", 
            "givenName": "Brian I.", 
            "id": "sg:person.01113325143.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113325143.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Gustave Roussy, Villejuif, France", 
              "id": "http://www.grid.ac/institutes/grid.14925.3b", 
              "name": [
                "Gustave Roussy, Villejuif, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Escudier", 
            "givenName": "Bernard", 
            "id": "sg:person.01304252172.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304252172.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of California, San Francisco School of Medicine, San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.266102.1", 
              "name": [
                "University of California, San Francisco School of Medicine, San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fong", 
            "givenName": "Lawrence", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Mayo Clinic Hospital \u2013 Florida, Jacksonville, FL, USA", 
              "id": "http://www.grid.ac/institutes/grid.417467.7", 
              "name": [
                "Mayo Clinic Hospital \u2013 Florida, Jacksonville, FL, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Joseph", 
            "givenName": "Richard W.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "City of Hope Comprehensive Cancer Center, Duarte, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "City of Hope Comprehensive Cancer Center, Duarte, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pal", 
            "givenName": "Sumanta K.", 
            "id": "sg:person.01162002222.57", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162002222.57"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Florida Cancer Specialists, Fort Myers, FL, USA", 
              "id": "http://www.grid.ac/institutes/grid.428633.8", 
              "name": [
                "Florida Cancer Specialists, Fort Myers, FL, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Reeves", 
            "givenName": "James A.", 
            "id": "sg:person.01050163235.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050163235.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yale School of Medicine, New Haven, CT, USA", 
              "id": "http://www.grid.ac/institutes/grid.47100.32", 
              "name": [
                "Yale School of Medicine, New Haven, CT, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sznol", 
            "givenName": "Mario", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Sarah Cannon Research Institute, Nashville, TN, USA", 
              "id": "http://www.grid.ac/institutes/grid.419513.b", 
              "name": [
                "Sarah Cannon Research Institute, Nashville, TN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hainsworth", 
            "givenName": "John", 
            "id": "sg:person.01076434551.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076434551.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Vanderbilt University Medical Center, Nashville, TN, USA", 
              "id": "http://www.grid.ac/institutes/grid.412807.8", 
              "name": [
                "Vanderbilt University Medical Center, Nashville, TN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rathmell", 
            "givenName": "W. Kimryn", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Chicago Medicine, Chicago, IL, USA", 
              "id": "http://www.grid.ac/institutes/grid.170205.1", 
              "name": [
                "University of Chicago Medicine, Chicago, IL, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stadler", 
            "givenName": "Walter M.", 
            "id": "sg:person.01331545003.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331545003.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Texas Oncology \u2013 Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA", 
              "id": "http://www.grid.ac/institutes/grid.486749.0", 
              "name": [
                "Texas Oncology \u2013 Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hutson", 
            "givenName": "Thomas", 
            "id": "sg:person.0626761272.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626761272.86"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Royal Marsden Hospital, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.424926.f", 
              "name": [
                "Royal Marsden Hospital, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gore", 
            "givenName": "Martin E.", 
            "id": "sg:person.012024134677.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012024134677.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "CHU Hopitaux de Bordeaux \u2013 H\u00f4pital Saint-Andr\u00e9, Bordeaux, France", 
              "id": "http://www.grid.ac/institutes/grid.42399.35", 
              "name": [
                "CHU Hopitaux de Bordeaux \u2013 H\u00f4pital Saint-Andr\u00e9, Bordeaux, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ravaud", 
            "givenName": "Alain", 
            "id": "sg:person.01077045011.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077045011.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ospedale San Donato, Azienda USL Toscana Sudest, Arezzo, Italy", 
              "id": "http://www.grid.ac/institutes/grid.416351.4", 
              "name": [
                "Ospedale San Donato, Azienda USL Toscana Sudest, Arezzo, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bracarda", 
            "givenName": "Sergio", 
            "id": "sg:person.0672107754.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672107754.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Vall d\u2019Hebron Institute of Oncology, Vall d\u2019Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.411083.f", 
              "name": [
                "Vall d\u2019Hebron Institute of Oncology, Vall d\u2019Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Su\u00e1rez", 
            "givenName": "Cristina", 
            "id": "sg:person.01231064061.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231064061.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Azienda Ospedaliera Universitaria Senese, Center for Immune-Oncology, Siena, Italy", 
              "id": "http://www.grid.ac/institutes/grid.411477.0", 
              "name": [
                "Azienda Ospedaliera Universitaria Senese, Center for Immune-Oncology, Siena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Danielli", 
            "givenName": "Riccardo", 
            "id": "sg:person.01070050076.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070050076.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medizinische Hochschule, Zentrum Innere Medizin, Abt. H\u00e4matologie u. Onkologie, Hannover, Germany", 
              "id": "http://www.grid.ac/institutes/grid.10423.34", 
              "name": [
                "Medizinische Hochschule, Zentrum Innere Medizin, Abt. H\u00e4matologie u. Onkologie, Hannover, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gruenwald", 
            "givenName": "Viktor", 
            "id": "sg:person.01315730111.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315730111.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dana-Farber Cancer Institute, Boston, MA, USA", 
              "id": "http://www.grid.ac/institutes/grid.65499.37", 
              "name": [
                "Dana-Farber Cancer Institute, Boston, MA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Choueiri", 
            "givenName": "Toni K.", 
            "id": "sg:person.01155331400.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155331400.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nickles", 
            "givenName": "Dorothee", 
            "id": "sg:person.013061506555.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013061506555.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jhunjhunwala", 
            "givenName": "Suchit", 
            "id": "sg:person.0641664231.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641664231.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Piault-Louis", 
            "givenName": "Elisabeth", 
            "id": "sg:person.01220634045.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220634045.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Roche Products Ltd, Welwyn Garden City, UK", 
              "id": "http://www.grid.ac/institutes/grid.419227.b", 
              "name": [
                "Roche Products Ltd, Welwyn Garden City, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Thobhani", 
            "givenName": "Alpa", 
            "id": "sg:person.015505557624.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015505557624.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Qiu", 
            "givenName": "Jiaheng", 
            "id": "sg:person.015276413565.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015276413565.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chen", 
            "givenName": "Daniel S.", 
            "id": "sg:person.01322305502.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322305502.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hegde", 
            "givenName": "Priti S.", 
            "id": "sg:person.01027574444.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027574444.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schiff", 
            "givenName": "Christina", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genentech, Inc., South San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Genentech, Inc., South San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fine", 
            "givenName": "Gregg D.", 
            "id": "sg:person.0747202132.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747202132.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Barts Cancer Institute and the Royal Free Hospital, Queen Mary University of London, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.4868.2", 
              "name": [
                "Barts Cancer Institute and the Royal Free Hospital, Queen Mary University of London, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Powles", 
            "givenName": "Thomas", 
            "id": "sg:person.0664224756.85", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664224756.85"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/ncomms12624", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050269937", 
              "https://doi.org/10.1038/ncomms12624"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature01322", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019336134", 
              "https://doi.org/10.1038/nature01322"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature14011", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041312915", 
              "https://doi.org/10.1038/nature14011"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13059-016-0974-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005070991", 
              "https://doi.org/10.1186/s13059-016-0974-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nri2506", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006865477", 
              "https://doi.org/10.1038/nri2506"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12307-014-0160-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033571510", 
              "https://doi.org/10.1007/s12307-014-0160-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4939-3578-9_15", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023750510", 
              "https://doi.org/10.1007/978-1-4939-3578-9_15"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00262-007-0441-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027279526", 
              "https://doi.org/10.1007/s00262-007-0441-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.3344", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005491724", 
              "https://doi.org/10.1038/nbt.3344"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00251-011-0579-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044405021", 
              "https://doi.org/10.1007/s00251-011-0579-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/2051-1426-3-s2-p83", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028339274", 
              "https://doi.org/10.1186/2051-1426-3-s2-p83"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-06-04", 
        "datePublishedReg": "2018-06-04", 
        "description": "We describe results from IMmotion150, a randomized phase 2 study of atezolizumab (anti-PD-L1) alone or combined with bevacizumab (anti-VEGF) versus sunitinib in 305 patients with treatment-naive metastatic renal cell carcinoma. Co-primary endpoints were progression-free survival (PFS) in intent-to-treat and PD-L1+ populations. Intent-to-treat PFS hazard ratios for atezolizumab\u2009+\u2009bevacizumab or atezolizumab monotherapy versus sunitinib were 1.0 (95% confidence interval (CI), 0.69\u20131.45) and 1.19 (95% CI, 0.82\u20131.71), respectively; PD-L1+ PFS hazard ratios were 0.64 (95% CI, 0.38\u20131.08) and 1.03 (95% CI, 0.63\u20131.67), respectively. Exploratory biomarker analyses indicated that tumor mutation and neoantigen burden were not associated with PFS. Angiogenesis, T-effector/IFN-\u03b3 response, and myeloid inflammatory gene expression signatures were strongly and differentially associated with PFS within and across the treatments. These molecular profiles suggest that prediction of outcomes with anti-VEGF and immunotherapy may be possible and offer mechanistic insights into how blocking VEGF may overcome resistance to immune checkpoint blockade.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41591-018-0053-3", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2440200", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2438810", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2438793", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2438863", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1113716", 
            "issn": [
              "1078-8956", 
              "1546-170X"
            ], 
            "name": "Nature Medicine", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "24"
          }
        ], 
        "keywords": [
          "progression-free survival", 
          "PFS hazard ratio", 
          "renal cell carcinoma", 
          "hazard ratio", 
          "PD-L1", 
          "cell carcinoma", 
          "treatment-naive metastatic renal-cell carcinoma", 
          "randomized phase 2 study", 
          "metastatic renal cell carcinoma", 
          "inflammatory gene expression signature", 
          "exploratory biomarker analysis", 
          "phase 2 study", 
          "immune checkpoint blockade", 
          "co-primary endpoints", 
          "prediction of outcome", 
          "atezolizumab monotherapy", 
          "neoantigen burden", 
          "gene expression signatures", 
          "checkpoint blockade", 
          "T effectors", 
          "clinical activity", 
          "atezolizumab", 
          "bevacizumab", 
          "tumor mutations", 
          "sunitinib", 
          "molecular correlates", 
          "molecular profile", 
          "expression signatures", 
          "carcinoma", 
          "biomarker analysis", 
          "monotherapy", 
          "immunotherapy", 
          "patients", 
          "blockade", 
          "endpoint", 
          "VEGF", 
          "angiogenesis", 
          "survival", 
          "outcomes", 
          "treatment", 
          "burden", 
          "mechanistic insights", 
          "treat", 
          "correlates", 
          "intent", 
          "population", 
          "mutations", 
          "response", 
          "activity", 
          "study", 
          "ratio", 
          "resistance", 
          "profile", 
          "combination", 
          "analysis", 
          "results", 
          "insights", 
          "signatures", 
          "prediction"
        ], 
        "name": "Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma", 
        "pagination": "749-757", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1104306675"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41591-018-0053-3"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "29867230"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41591-018-0053-3", 
          "https://app.dimensions.ai/details/publication/pub.1104306675"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-08-04T17:06", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_769.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41591-018-0053-3"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41591-018-0053-3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41591-018-0053-3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41591-018-0053-3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41591-018-0053-3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    529 TRIPLES      21 PREDICATES      114 URIs      95 LITERALS      26 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41591-018-0053-3 schema:about N0576d821da744c89b6e3718319405da6
    2 N117dc1e891ea45aea9f300e07ce2eeab
    3 N176a97d06193447f90be32bf376d7c99
    4 N230dff2a6567414bb1e61f17a1e68e06
    5 N2cc638a1d4d2429d92aca4fe1bb4e06b
    6 N4761e21adf13430da878a3c085d1612a
    7 N52a5256768ed4547b85d87d276622788
    8 N53b2b3e268b849ba8b6f9b5c04cd8477
    9 N53d701e7100940a5993edc23487fdc79
    10 N54bc6fcb121848a7a78fb2f074a25bf2
    11 N796c4868622a43bdb8cd325a9a2061ed
    12 N7e5bea09114041c289cd29c8ae1f3f70
    13 N89bb0bcd247b4a928f9ec72f503095cc
    14 N8aece305c58249cf80f64e05aa12725a
    15 N92d99431cca8448aa7b583abebcf5b3e
    16 N9f53483b9e2440d8969fa903927c4671
    17 Na6fb0d80c83c4c9abfdc9656d01bb07b
    18 Nd9d96600e2e3498096be048389fa504e
    19 Nf540504401264414ad2f273b62f22351
    20 anzsrc-for:11
    21 anzsrc-for:1112
    22 schema:author N459fdf05841246bb8a46e4ebfadc9b5b
    23 schema:citation sg:pub.10.1007/978-1-4939-3578-9_15
    24 sg:pub.10.1007/s00251-011-0579-8
    25 sg:pub.10.1007/s00262-007-0441-x
    26 sg:pub.10.1007/s12307-014-0160-8
    27 sg:pub.10.1038/nature01322
    28 sg:pub.10.1038/nature14011
    29 sg:pub.10.1038/nbt.3344
    30 sg:pub.10.1038/ncomms12624
    31 sg:pub.10.1038/nri2506
    32 sg:pub.10.1186/2051-1426-3-s2-p83
    33 sg:pub.10.1186/s13059-016-0974-4
    34 schema:datePublished 2018-06-04
    35 schema:datePublishedReg 2018-06-04
    36 schema:description We describe results from IMmotion150, a randomized phase 2 study of atezolizumab (anti-PD-L1) alone or combined with bevacizumab (anti-VEGF) versus sunitinib in 305 patients with treatment-naive metastatic renal cell carcinoma. Co-primary endpoints were progression-free survival (PFS) in intent-to-treat and PD-L1+ populations. Intent-to-treat PFS hazard ratios for atezolizumab + bevacizumab or atezolizumab monotherapy versus sunitinib were 1.0 (95% confidence interval (CI), 0.69–1.45) and 1.19 (95% CI, 0.82–1.71), respectively; PD-L1+ PFS hazard ratios were 0.64 (95% CI, 0.38–1.08) and 1.03 (95% CI, 0.63–1.67), respectively. Exploratory biomarker analyses indicated that tumor mutation and neoantigen burden were not associated with PFS. Angiogenesis, T-effector/IFN-γ response, and myeloid inflammatory gene expression signatures were strongly and differentially associated with PFS within and across the treatments. These molecular profiles suggest that prediction of outcomes with anti-VEGF and immunotherapy may be possible and offer mechanistic insights into how blocking VEGF may overcome resistance to immune checkpoint blockade.
    37 schema:genre article
    38 schema:isAccessibleForFree true
    39 schema:isPartOf N29f85ece57654903a0bbc9357540328a
    40 N4c9bac5de5fe4bcda93009832938b45a
    41 sg:journal.1113716
    42 schema:keywords PD-L1
    43 PFS hazard ratio
    44 T effectors
    45 VEGF
    46 activity
    47 analysis
    48 angiogenesis
    49 atezolizumab
    50 atezolizumab monotherapy
    51 bevacizumab
    52 biomarker analysis
    53 blockade
    54 burden
    55 carcinoma
    56 cell carcinoma
    57 checkpoint blockade
    58 clinical activity
    59 co-primary endpoints
    60 combination
    61 correlates
    62 endpoint
    63 exploratory biomarker analysis
    64 expression signatures
    65 gene expression signatures
    66 hazard ratio
    67 immune checkpoint blockade
    68 immunotherapy
    69 inflammatory gene expression signature
    70 insights
    71 intent
    72 mechanistic insights
    73 metastatic renal cell carcinoma
    74 molecular correlates
    75 molecular profile
    76 monotherapy
    77 mutations
    78 neoantigen burden
    79 outcomes
    80 patients
    81 phase 2 study
    82 population
    83 prediction
    84 prediction of outcome
    85 profile
    86 progression-free survival
    87 randomized phase 2 study
    88 ratio
    89 renal cell carcinoma
    90 resistance
    91 response
    92 results
    93 signatures
    94 study
    95 sunitinib
    96 survival
    97 treat
    98 treatment
    99 treatment-naive metastatic renal-cell carcinoma
    100 tumor mutations
    101 schema:name Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
    102 schema:pagination 749-757
    103 schema:productId N70e53b495c104630a29584f1119c9b92
    104 N9177fb6f438a4b798d7e45ca690b0c6d
    105 Nc3586ea4510b47df9f3945656055fb47
    106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104306675
    107 https://doi.org/10.1038/s41591-018-0053-3
    108 schema:sdDatePublished 2022-08-04T17:06
    109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    110 schema:sdPublisher Nbf43a0e881324639a39bd56153af5f9c
    111 schema:url https://doi.org/10.1038/s41591-018-0053-3
    112 sgo:license sg:explorer/license/
    113 sgo:sdDataset articles
    114 rdf:type schema:ScholarlyArticle
    115 N0110a542b2f34caf94084891891e7a23 rdf:first N9e869532053d4ef3a70075955cd06ad2
    116 rdf:rest N88f8f243899b41449c20ab01db0f4074
    117 N0576d821da744c89b6e3718319405da6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Bevacizumab
    119 rdf:type schema:DefinedTerm
    120 N117dc1e891ea45aea9f300e07ce2eeab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Antibodies, Monoclonal, Humanized
    122 rdf:type schema:DefinedTerm
    123 N176a97d06193447f90be32bf376d7c99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Female
    125 rdf:type schema:DefinedTerm
    126 N1e598139159442ba9aacd452ef6b1354 rdf:first sg:person.0672107754.22
    127 rdf:rest N215fa53c29aa4ab6bf1637ac83fac219
    128 N215fa53c29aa4ab6bf1637ac83fac219 rdf:first sg:person.01231064061.05
    129 rdf:rest Nde41078b16724a0bb0c2acf7b852b651
    130 N230dff2a6567414bb1e61f17a1e68e06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Antineoplastic Combined Chemotherapy Protocols
    132 rdf:type schema:DefinedTerm
    133 N2935fc20abea4e699cec3d8be00bfeff rdf:first N9bd8b9c895b24fc1853c741562e4e873
    134 rdf:rest N47e5fba212674b66967a1c55f9732589
    135 N29f85ece57654903a0bbc9357540328a schema:issueNumber 6
    136 rdf:type schema:PublicationIssue
    137 N2b1ea29ce7a741269308e3f25b81b3c2 rdf:first sg:person.013061506555.12
    138 rdf:rest N91660cc938d9486684e9af19a273321f
    139 N2cc638a1d4d2429d92aca4fe1bb4e06b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Kaplan-Meier Estimate
    141 rdf:type schema:DefinedTerm
    142 N310fc3895630450cb8f66ba42f9506c9 schema:affiliation grid-institutes:grid.417467.7
    143 schema:familyName Joseph
    144 schema:givenName Richard W.
    145 rdf:type schema:Person
    146 N394603ce62224879af80e599f2438963 rdf:first Nac41ec66e8d149d8903e389fdca3d43b
    147 rdf:rest N6930bd4c8dc9414b938de62b94cc4bfb
    148 N39f79677dfdc498692e0ab1b71ec31a7 rdf:first sg:person.01304252172.82
    149 rdf:rest N0110a542b2f34caf94084891891e7a23
    150 N459fdf05841246bb8a46e4ebfadc9b5b rdf:first sg:person.0656541200.82
    151 rdf:rest Nd2e669fa78f044138b7ffcf2bca5aa9d
    152 N468ead9271744adcbddc655daa0aa2d0 rdf:first sg:person.015276413565.20
    153 rdf:rest N531ee67c92e04626a9dac4748f11cc76
    154 N4761e21adf13430da878a3c085d1612a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Carcinoma, Renal Cell
    156 rdf:type schema:DefinedTerm
    157 N47e5fba212674b66967a1c55f9732589 rdf:first sg:person.01076434551.26
    158 rdf:rest Nbc7d26f592e345d9afc02f89dc3daaa4
    159 N4b648efdc86d430390df63f3edf7063a rdf:first sg:person.01162002222.57
    160 rdf:rest N80f31223804f425da5a246e935c0fbd7
    161 N4c9bac5de5fe4bcda93009832938b45a schema:volumeNumber 24
    162 rdf:type schema:PublicationVolume
    163 N4d1da6597eed451bb1748130b1e7af5d rdf:first sg:person.01113325143.17
    164 rdf:rest N39f79677dfdc498692e0ab1b71ec31a7
    165 N52a5256768ed4547b85d87d276622788 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Antibodies, Monoclonal
    167 rdf:type schema:DefinedTerm
    168 N531ee67c92e04626a9dac4748f11cc76 rdf:first sg:person.01322305502.12
    169 rdf:rest N71b543b6c97f4b84bddb218b02558153
    170 N53b2b3e268b849ba8b6f9b5c04cd8477 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Treatment Outcome
    172 rdf:type schema:DefinedTerm
    173 N53d701e7100940a5993edc23487fdc79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Gene Expression Profiling
    175 rdf:type schema:DefinedTerm
    176 N54bc6fcb121848a7a78fb2f074a25bf2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Gene Expression Regulation, Neoplastic
    178 rdf:type schema:DefinedTerm
    179 N5c71579e031b4c7bbecce36384300a76 rdf:first sg:person.010266621557.13
    180 rdf:rest N7d2b447234404bafbf57031778eb9c4e
    181 N61e9ab46a3ec4bca973c9179240037f9 rdf:first sg:person.012024134677.17
    182 rdf:rest Na3cde151db864b6884bcab36f140cf9a
    183 N6930bd4c8dc9414b938de62b94cc4bfb rdf:first sg:person.0747202132.06
    184 rdf:rest Nc1f5fbe6e2224874ab0fd1ddf28dc8a3
    185 N70e53b495c104630a29584f1119c9b92 schema:name doi
    186 schema:value 10.1038/s41591-018-0053-3
    187 rdf:type schema:PropertyValue
    188 N71b543b6c97f4b84bddb218b02558153 rdf:first sg:person.01027574444.74
    189 rdf:rest N394603ce62224879af80e599f2438963
    190 N76921f174b26414f8279a3b5ec686de3 rdf:first sg:person.01220634045.07
    191 rdf:rest Nb3e17f3cb6924a14baaade6aec683d06
    192 N796c4868622a43bdb8cd325a9a2061ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Male
    194 rdf:type schema:DefinedTerm
    195 N7d2b447234404bafbf57031778eb9c4e rdf:first sg:person.01234500340.18
    196 rdf:rest N4d1da6597eed451bb1748130b1e7af5d
    197 N7e5bea09114041c289cd29c8ae1f3f70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Adult
    199 rdf:type schema:DefinedTerm
    200 N80f31223804f425da5a246e935c0fbd7 rdf:first sg:person.01050163235.47
    201 rdf:rest N2935fc20abea4e699cec3d8be00bfeff
    202 N88f8f243899b41449c20ab01db0f4074 rdf:first N310fc3895630450cb8f66ba42f9506c9
    203 rdf:rest N4b648efdc86d430390df63f3edf7063a
    204 N89bb0bcd247b4a928f9ec72f503095cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Kidney Neoplasms
    206 rdf:type schema:DefinedTerm
    207 N8aece305c58249cf80f64e05aa12725a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    208 schema:name Middle Aged
    209 rdf:type schema:DefinedTerm
    210 N8c5865714e4f4523b45f15e7ad00685f rdf:first sg:person.0626761272.86
    211 rdf:rest N61e9ab46a3ec4bca973c9179240037f9
    212 N91660cc938d9486684e9af19a273321f rdf:first sg:person.0641664231.06
    213 rdf:rest N76921f174b26414f8279a3b5ec686de3
    214 N9177fb6f438a4b798d7e45ca690b0c6d schema:name pubmed_id
    215 schema:value 29867230
    216 rdf:type schema:PropertyValue
    217 N92d99431cca8448aa7b583abebcf5b3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    218 schema:name Mutation
    219 rdf:type schema:DefinedTerm
    220 N9bd8b9c895b24fc1853c741562e4e873 schema:affiliation grid-institutes:grid.47100.32
    221 schema:familyName Sznol
    222 schema:givenName Mario
    223 rdf:type schema:Person
    224 N9e869532053d4ef3a70075955cd06ad2 schema:affiliation grid-institutes:grid.266102.1
    225 schema:familyName Fong
    226 schema:givenName Lawrence
    227 rdf:type schema:Person
    228 N9f53483b9e2440d8969fa903927c4671 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    229 schema:name Humans
    230 rdf:type schema:DefinedTerm
    231 Na3cde151db864b6884bcab36f140cf9a rdf:first sg:person.01077045011.19
    232 rdf:rest N1e598139159442ba9aacd452ef6b1354
    233 Na6fb0d80c83c4c9abfdc9656d01bb07b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    234 schema:name Aged, 80 and over
    235 rdf:type schema:DefinedTerm
    236 Nac41ec66e8d149d8903e389fdca3d43b schema:affiliation grid-institutes:grid.418158.1
    237 schema:familyName Schiff
    238 schema:givenName Christina
    239 rdf:type schema:Person
    240 Nb3e17f3cb6924a14baaade6aec683d06 rdf:first sg:person.015505557624.31
    241 rdf:rest N468ead9271744adcbddc655daa0aa2d0
    242 Nbc7d26f592e345d9afc02f89dc3daaa4 rdf:first Ne8b03d5c00e345e7aada1c3985b8d7c4
    243 rdf:rest Ndb4c3d00e57548708bded5839bb1c3bb
    244 Nbf43a0e881324639a39bd56153af5f9c schema:name Springer Nature - SN SciGraph project
    245 rdf:type schema:Organization
    246 Nc1f5fbe6e2224874ab0fd1ddf28dc8a3 rdf:first sg:person.0664224756.85
    247 rdf:rest rdf:nil
    248 Nc3586ea4510b47df9f3945656055fb47 schema:name dimensions_id
    249 schema:value pub.1104306675
    250 rdf:type schema:PropertyValue
    251 Nd2e669fa78f044138b7ffcf2bca5aa9d rdf:first sg:person.013034331475.00
    252 rdf:rest N5c71579e031b4c7bbecce36384300a76
    253 Nd9d96600e2e3498096be048389fa504e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    254 schema:name Sunitinib
    255 rdf:type schema:DefinedTerm
    256 Ndb4c3d00e57548708bded5839bb1c3bb rdf:first sg:person.01331545003.30
    257 rdf:rest N8c5865714e4f4523b45f15e7ad00685f
    258 Nde41078b16724a0bb0c2acf7b852b651 rdf:first sg:person.01070050076.50
    259 rdf:rest Neae9f9829eab4e9c90169d0e88f50fc8
    260 Ne8b03d5c00e345e7aada1c3985b8d7c4 schema:affiliation grid-institutes:grid.412807.8
    261 schema:familyName Rathmell
    262 schema:givenName W. Kimryn
    263 rdf:type schema:Person
    264 Neae9f9829eab4e9c90169d0e88f50fc8 rdf:first sg:person.01315730111.15
    265 rdf:rest Nfa92ff9e8cf64b6e916d1c4cb37eef9b
    266 Nf540504401264414ad2f273b62f22351 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    267 schema:name Aged
    268 rdf:type schema:DefinedTerm
    269 Nfa92ff9e8cf64b6e916d1c4cb37eef9b rdf:first sg:person.01155331400.39
    270 rdf:rest N2b1ea29ce7a741269308e3f25b81b3c2
    271 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    272 schema:name Medical and Health Sciences
    273 rdf:type schema:DefinedTerm
    274 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    275 schema:name Oncology and Carcinogenesis
    276 rdf:type schema:DefinedTerm
    277 sg:grant.2438793 http://pending.schema.org/fundedItem sg:pub.10.1038/s41591-018-0053-3
    278 rdf:type schema:MonetaryGrant
    279 sg:grant.2438810 http://pending.schema.org/fundedItem sg:pub.10.1038/s41591-018-0053-3
    280 rdf:type schema:MonetaryGrant
    281 sg:grant.2438863 http://pending.schema.org/fundedItem sg:pub.10.1038/s41591-018-0053-3
    282 rdf:type schema:MonetaryGrant
    283 sg:grant.2440200 http://pending.schema.org/fundedItem sg:pub.10.1038/s41591-018-0053-3
    284 rdf:type schema:MonetaryGrant
    285 sg:journal.1113716 schema:issn 1078-8956
    286 1546-170X
    287 schema:name Nature Medicine
    288 schema:publisher Springer Nature
    289 rdf:type schema:Periodical
    290 sg:person.010266621557.13 schema:affiliation grid-institutes:grid.213910.8
    291 schema:familyName Atkins
    292 schema:givenName Michael B.
    293 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010266621557.13
    294 rdf:type schema:Person
    295 sg:person.01027574444.74 schema:affiliation grid-institutes:grid.418158.1
    296 schema:familyName Hegde
    297 schema:givenName Priti S.
    298 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027574444.74
    299 rdf:type schema:Person
    300 sg:person.01050163235.47 schema:affiliation grid-institutes:grid.428633.8
    301 schema:familyName Reeves
    302 schema:givenName James A.
    303 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050163235.47
    304 rdf:type schema:Person
    305 sg:person.01070050076.50 schema:affiliation grid-institutes:grid.411477.0
    306 schema:familyName Danielli
    307 schema:givenName Riccardo
    308 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070050076.50
    309 rdf:type schema:Person
    310 sg:person.01076434551.26 schema:affiliation grid-institutes:grid.419513.b
    311 schema:familyName Hainsworth
    312 schema:givenName John
    313 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076434551.26
    314 rdf:type schema:Person
    315 sg:person.01077045011.19 schema:affiliation grid-institutes:grid.42399.35
    316 schema:familyName Ravaud
    317 schema:givenName Alain
    318 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077045011.19
    319 rdf:type schema:Person
    320 sg:person.01113325143.17 schema:affiliation grid-institutes:grid.239578.2
    321 schema:familyName Rini
    322 schema:givenName Brian I.
    323 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113325143.17
    324 rdf:type schema:Person
    325 sg:person.01155331400.39 schema:affiliation grid-institutes:grid.65499.37
    326 schema:familyName Choueiri
    327 schema:givenName Toni K.
    328 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155331400.39
    329 rdf:type schema:Person
    330 sg:person.01162002222.57 schema:affiliation grid-institutes:grid.410425.6
    331 schema:familyName Pal
    332 schema:givenName Sumanta K.
    333 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162002222.57
    334 rdf:type schema:Person
    335 sg:person.012024134677.17 schema:affiliation grid-institutes:grid.424926.f
    336 schema:familyName Gore
    337 schema:givenName Martin E.
    338 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012024134677.17
    339 rdf:type schema:Person
    340 sg:person.01220634045.07 schema:affiliation grid-institutes:grid.418158.1
    341 schema:familyName Piault-Louis
    342 schema:givenName Elisabeth
    343 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220634045.07
    344 rdf:type schema:Person
    345 sg:person.01231064061.05 schema:affiliation grid-institutes:grid.411083.f
    346 schema:familyName Suárez
    347 schema:givenName Cristina
    348 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231064061.05
    349 rdf:type schema:Person
    350 sg:person.01234500340.18 schema:affiliation grid-institutes:grid.51462.34
    351 schema:familyName Motzer
    352 schema:givenName Robert J.
    353 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234500340.18
    354 rdf:type schema:Person
    355 sg:person.013034331475.00 schema:affiliation grid-institutes:grid.418158.1
    356 schema:familyName Huseni
    357 schema:givenName Mahrukh A.
    358 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013034331475.00
    359 rdf:type schema:Person
    360 sg:person.01304252172.82 schema:affiliation grid-institutes:grid.14925.3b
    361 schema:familyName Escudier
    362 schema:givenName Bernard
    363 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304252172.82
    364 rdf:type schema:Person
    365 sg:person.013061506555.12 schema:affiliation grid-institutes:grid.418158.1
    366 schema:familyName Nickles
    367 schema:givenName Dorothee
    368 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013061506555.12
    369 rdf:type schema:Person
    370 sg:person.01315730111.15 schema:affiliation grid-institutes:grid.10423.34
    371 schema:familyName Gruenwald
    372 schema:givenName Viktor
    373 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315730111.15
    374 rdf:type schema:Person
    375 sg:person.01322305502.12 schema:affiliation grid-institutes:grid.418158.1
    376 schema:familyName Chen
    377 schema:givenName Daniel S.
    378 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322305502.12
    379 rdf:type schema:Person
    380 sg:person.01331545003.30 schema:affiliation grid-institutes:grid.170205.1
    381 schema:familyName Stadler
    382 schema:givenName Walter M.
    383 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331545003.30
    384 rdf:type schema:Person
    385 sg:person.015276413565.20 schema:affiliation grid-institutes:grid.418158.1
    386 schema:familyName Qiu
    387 schema:givenName Jiaheng
    388 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015276413565.20
    389 rdf:type schema:Person
    390 sg:person.015505557624.31 schema:affiliation grid-institutes:grid.419227.b
    391 schema:familyName Thobhani
    392 schema:givenName Alpa
    393 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015505557624.31
    394 rdf:type schema:Person
    395 sg:person.0626761272.86 schema:affiliation grid-institutes:grid.486749.0
    396 schema:familyName Hutson
    397 schema:givenName Thomas
    398 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626761272.86
    399 rdf:type schema:Person
    400 sg:person.0641664231.06 schema:affiliation grid-institutes:grid.418158.1
    401 schema:familyName Jhunjhunwala
    402 schema:givenName Suchit
    403 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641664231.06
    404 rdf:type schema:Person
    405 sg:person.0656541200.82 schema:affiliation grid-institutes:grid.239395.7
    406 schema:familyName McDermott
    407 schema:givenName David F.
    408 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656541200.82
    409 rdf:type schema:Person
    410 sg:person.0664224756.85 schema:affiliation grid-institutes:grid.4868.2
    411 schema:familyName Powles
    412 schema:givenName Thomas
    413 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664224756.85
    414 rdf:type schema:Person
    415 sg:person.0672107754.22 schema:affiliation grid-institutes:grid.416351.4
    416 schema:familyName Bracarda
    417 schema:givenName Sergio
    418 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672107754.22
    419 rdf:type schema:Person
    420 sg:person.0747202132.06 schema:affiliation grid-institutes:grid.418158.1
    421 schema:familyName Fine
    422 schema:givenName Gregg D.
    423 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747202132.06
    424 rdf:type schema:Person
    425 sg:pub.10.1007/978-1-4939-3578-9_15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023750510
    426 https://doi.org/10.1007/978-1-4939-3578-9_15
    427 rdf:type schema:CreativeWork
    428 sg:pub.10.1007/s00251-011-0579-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044405021
    429 https://doi.org/10.1007/s00251-011-0579-8
    430 rdf:type schema:CreativeWork
    431 sg:pub.10.1007/s00262-007-0441-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027279526
    432 https://doi.org/10.1007/s00262-007-0441-x
    433 rdf:type schema:CreativeWork
    434 sg:pub.10.1007/s12307-014-0160-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033571510
    435 https://doi.org/10.1007/s12307-014-0160-8
    436 rdf:type schema:CreativeWork
    437 sg:pub.10.1038/nature01322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019336134
    438 https://doi.org/10.1038/nature01322
    439 rdf:type schema:CreativeWork
    440 sg:pub.10.1038/nature14011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041312915
    441 https://doi.org/10.1038/nature14011
    442 rdf:type schema:CreativeWork
    443 sg:pub.10.1038/nbt.3344 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005491724
    444 https://doi.org/10.1038/nbt.3344
    445 rdf:type schema:CreativeWork
    446 sg:pub.10.1038/ncomms12624 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050269937
    447 https://doi.org/10.1038/ncomms12624
    448 rdf:type schema:CreativeWork
    449 sg:pub.10.1038/nri2506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006865477
    450 https://doi.org/10.1038/nri2506
    451 rdf:type schema:CreativeWork
    452 sg:pub.10.1186/2051-1426-3-s2-p83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028339274
    453 https://doi.org/10.1186/2051-1426-3-s2-p83
    454 rdf:type schema:CreativeWork
    455 sg:pub.10.1186/s13059-016-0974-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005070991
    456 https://doi.org/10.1186/s13059-016-0974-4
    457 rdf:type schema:CreativeWork
    458 grid-institutes:grid.10423.34 schema:alternateName Medizinische Hochschule, Zentrum Innere Medizin, Abt. Hämatologie u. Onkologie, Hannover, Germany
    459 schema:name Medizinische Hochschule, Zentrum Innere Medizin, Abt. Hämatologie u. Onkologie, Hannover, Germany
    460 rdf:type schema:Organization
    461 grid-institutes:grid.14925.3b schema:alternateName Gustave Roussy, Villejuif, France
    462 schema:name Gustave Roussy, Villejuif, France
    463 rdf:type schema:Organization
    464 grid-institutes:grid.170205.1 schema:alternateName University of Chicago Medicine, Chicago, IL, USA
    465 schema:name University of Chicago Medicine, Chicago, IL, USA
    466 rdf:type schema:Organization
    467 grid-institutes:grid.213910.8 schema:alternateName Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA
    468 schema:name Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA
    469 rdf:type schema:Organization
    470 grid-institutes:grid.239395.7 schema:alternateName Beth Israel Deaconess Medical Center, Boston, MA, USA
    471 schema:name Beth Israel Deaconess Medical Center, Boston, MA, USA
    472 rdf:type schema:Organization
    473 grid-institutes:grid.239578.2 schema:alternateName Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
    474 schema:name Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
    475 rdf:type schema:Organization
    476 grid-institutes:grid.266102.1 schema:alternateName University of California, San Francisco School of Medicine, San Francisco, CA, USA
    477 schema:name University of California, San Francisco School of Medicine, San Francisco, CA, USA
    478 rdf:type schema:Organization
    479 grid-institutes:grid.410425.6 schema:alternateName City of Hope Comprehensive Cancer Center, Duarte, CA, USA
    480 schema:name City of Hope Comprehensive Cancer Center, Duarte, CA, USA
    481 rdf:type schema:Organization
    482 grid-institutes:grid.411083.f schema:alternateName Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
    483 schema:name Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
    484 rdf:type schema:Organization
    485 grid-institutes:grid.411477.0 schema:alternateName Azienda Ospedaliera Universitaria Senese, Center for Immune-Oncology, Siena, Italy
    486 schema:name Azienda Ospedaliera Universitaria Senese, Center for Immune-Oncology, Siena, Italy
    487 rdf:type schema:Organization
    488 grid-institutes:grid.412807.8 schema:alternateName Vanderbilt University Medical Center, Nashville, TN, USA
    489 schema:name Vanderbilt University Medical Center, Nashville, TN, USA
    490 rdf:type schema:Organization
    491 grid-institutes:grid.416351.4 schema:alternateName Ospedale San Donato, Azienda USL Toscana Sudest, Arezzo, Italy
    492 schema:name Ospedale San Donato, Azienda USL Toscana Sudest, Arezzo, Italy
    493 rdf:type schema:Organization
    494 grid-institutes:grid.417467.7 schema:alternateName Mayo Clinic Hospital – Florida, Jacksonville, FL, USA
    495 schema:name Mayo Clinic Hospital – Florida, Jacksonville, FL, USA
    496 rdf:type schema:Organization
    497 grid-institutes:grid.418158.1 schema:alternateName Genentech, Inc., South San Francisco, CA, USA
    498 schema:name Genentech, Inc., South San Francisco, CA, USA
    499 rdf:type schema:Organization
    500 grid-institutes:grid.419227.b schema:alternateName Roche Products Ltd, Welwyn Garden City, UK
    501 schema:name Roche Products Ltd, Welwyn Garden City, UK
    502 rdf:type schema:Organization
    503 grid-institutes:grid.419513.b schema:alternateName Sarah Cannon Research Institute, Nashville, TN, USA
    504 schema:name Sarah Cannon Research Institute, Nashville, TN, USA
    505 rdf:type schema:Organization
    506 grid-institutes:grid.42399.35 schema:alternateName CHU Hopitaux de Bordeaux – Hôpital Saint-André, Bordeaux, France
    507 schema:name CHU Hopitaux de Bordeaux – Hôpital Saint-André, Bordeaux, France
    508 rdf:type schema:Organization
    509 grid-institutes:grid.424926.f schema:alternateName Royal Marsden Hospital, London, UK
    510 schema:name Royal Marsden Hospital, London, UK
    511 rdf:type schema:Organization
    512 grid-institutes:grid.428633.8 schema:alternateName Florida Cancer Specialists, Fort Myers, FL, USA
    513 schema:name Florida Cancer Specialists, Fort Myers, FL, USA
    514 rdf:type schema:Organization
    515 grid-institutes:grid.47100.32 schema:alternateName Yale School of Medicine, New Haven, CT, USA
    516 schema:name Yale School of Medicine, New Haven, CT, USA
    517 rdf:type schema:Organization
    518 grid-institutes:grid.486749.0 schema:alternateName Texas Oncology – Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA
    519 schema:name Texas Oncology – Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA
    520 rdf:type schema:Organization
    521 grid-institutes:grid.4868.2 schema:alternateName Barts Cancer Institute and the Royal Free Hospital, Queen Mary University of London, London, UK
    522 schema:name Barts Cancer Institute and the Royal Free Hospital, Queen Mary University of London, London, UK
    523 rdf:type schema:Organization
    524 grid-institutes:grid.51462.34 schema:alternateName Memorial Sloan Kettering Cancer Center, New York, NY, USA
    525 schema:name Memorial Sloan Kettering Cancer Center, New York, NY, USA
    526 rdf:type schema:Organization
    527 grid-institutes:grid.65499.37 schema:alternateName Dana-Farber Cancer Institute, Boston, MA, USA
    528 schema:name Dana-Farber Cancer Institute, Boston, MA, USA
    529 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...